Cefpodoxime

Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.

Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.

Cefpodoxime Proxetil and Potassium Clavulanate combines a third-generation cephalosporin with a beta-lactamase inhibitor. Clavulanic acid shields cefpodoxime from degradation by beta-lactamases produced by Staphylococcus aureus, H. influenzae, and enterobacteria. Indicated for community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute bacterial sinusitis, recurrent otitis media, and skin/soft tissue infections.

Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.

Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.

Cefpodoxime Proxetil is an orally absorbed prodrug of the third-generation cephalosporin cefpodoxime. Following absorption, it is de-esterified into active cefpodoxime, which inhibits bacterial cell wall synthesis. Active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Proteus mirabilis. Indicated for community-acquired pneumonia, acute otitis media, pharyngitis, sinusitis, uncomplicated skin infections, and uncomplicated UTIs.

Cefpodoxime Proxetil and Ofloxacin is a broad-spectrum combination of an oral 3rd-generation cephalosporin prodrug and a second-generation fluoroquinolone. Cefpodoxime blocks cell wall synthesis while ofloxacin halts DNA replication and transcription via bacterial DNA gyrase and topoisomerase IV inhibition. Indicated for mixed and resistant respiratory tract infections, enteric fever, and complicated skin or urinary infections.